These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38485427)

  • 1. Incidence of typhoid fever in Burkina Faso, Democratic Republic of the Congo, Ethiopia, Ghana, Madagascar, and Nigeria (the Severe Typhoid in Africa programme): a population-based study.
    Marks F; Im J; Park SE; Pak GD; Jeon HJ; Wandji Nana LR; Phoba MF; Mbuyi-Kalonji L; Mogeni OD; Yeshitela B; Panzner U; Cruz Espinoza LM; Beyene T; Owusu-Ansah M; Twumasi-Ankrah S; Yeshambaw M; Alemu A; Adewusi OJ; Adekanmbi O; Higginson E; Adepoju A; Agbi S; Cakpo EG; Ogunleye VO; Tunda GN; Ikhimiukor OO; Mbuyamba J; Toy T; Agyapong FO; Osei I; Amuasi J; Razafindrabe TJL; Raminosoa TM; Nyirenda G; Randriamampionona N; Seo HW; Seo H; Siribie M; Carey ME; Owusu M; Meyer CG; Rakotozandrindrainy N; Sarpong N; Razafindrakalia M; Razafimanantsoa R; Ouedraogo M; Kim YJ; Lee J; Zellweger RM; Kang SSY; Park JY; Crump JA; Hardy L; Jacobs J; Garrett DO; Andrews JR; Poudyal N; Kim DR; Clemens JD; Baker SG; Kim JH; Dougan G; Sugimoto JD; Van Puyvelde S; Kehinde A; Popoola OA; Mogasale V; Breiman RF; MacWright WR; Aseffa A; Tadesse BT; Haselbeck A; Adu-Sarkodie Y; Teferi M; Bassiahi AS; Okeke IN; Lunguya-Metila O; Owusu-Dabo E; Rakotozandrindrainy R
    Lancet Glob Health; 2024 Apr; 12(4):e599-e610. PubMed ID: 38485427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of invasive salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study.
    Marks F; von Kalckreuth V; Aaby P; Adu-Sarkodie Y; El Tayeb MA; Ali M; Aseffa A; Baker S; Biggs HM; Bjerregaard-Andersen M; Breiman RF; Campbell JI; Cosmas L; Crump JA; Espinoza LMC; Deerin JF; Dekker DM; Fields BS; Gasmelseed N; Hertz JT; Van Minh Hoang N; Im J; Jaeger A; Jeon HJ; Kabore LP; Keddy KH; Konings F; Krumkamp R; Ley B; Løfberg SV; May J; Meyer CG; Mintz ED; Montgomery JM; Niang AA; Nichols C; Olack B; Pak GD; Panzner U; Park JK; Park SE; Rabezanahary H; Rakotozandrindrainy R; Raminosoa TM; Razafindrabe TJL; Sampo E; Schütt-Gerowitt H; Sow AG; Sarpong N; Seo HJ; Sooka A; Soura AB; Tall A; Teferi M; Thriemer K; Warren MR; Yeshitela B; Clemens JD; Wierzba TF
    Lancet Glob Health; 2017 Mar; 5(3):e310-e323. PubMed ID: 28193398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Severe Typhoid Fever in Africa Program: Study Design and Methodology to Assess Disease Severity, Host Immunity, and Carriage Associated With Invasive Salmonellosis.
    Park SE; Toy T; Cruz Espinoza LM; Panzner U; Mogeni OD; Im J; Poudyal N; Pak GD; Seo H; Chon Y; Schütt-Gerowitt H; Mogasale V; Ramani E; Dey A; Park JY; Kim JH; Seo HJ; Jeon HJ; Haselbeck A; Conway Roy K; MacWright W; Adu-Sarkodie Y; Owusu-Dabo E; Osei I; Owusu M; Rakotozandrindrainy R; Soura AB; Kabore LP; Teferi M; Okeke IN; Kehinde A; Popoola O; Jacobs J; Lunguya Metila O; Meyer CG; Crump JA; Elias S; Maclennan CA; Parry CM; Baker S; Mintz ED; Breiman RF; Clemens JD; Marks F
    Clin Infect Dis; 2019 Oct; 69(Suppl 6):S422-S434. PubMed ID: 31665779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of typhoid and paratyphoid fever in Bangladesh, Nepal, and Pakistan: results of the Surveillance for Enteric Fever in Asia Project.
    Garrett DO; Longley AT; Aiemjoy K; Yousafzai MT; Hemlock C; Yu AT; Vaidya K; Tamrakar D; Saha S; Bogoch II; Date K; Saha S; Islam MS; Sayeed KMI; Bern C; Shakoor S; Dehraj IF; Mehmood J; Sajib MSI; Islam M; Thobani RS; Hotwani A; Rahman N; Irfan S; Naga SR; Memon AM; Pradhan S; Iqbal K; Shrestha R; Rahman H; Hasan MM; Qazi SH; Kazi AM; Saddal NS; Jamal R; Hunzai MJ; Hossain T; Marks F; Carter AS; Seidman JC; Qamar FN; Saha SK; Andrews JR; Luby SP
    Lancet Glob Health; 2022 Jul; 10(7):e978-e988. PubMed ID: 35714648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Can the Typhoid Fever Surveillance in Africa and the Severe Typhoid Fever in Africa Programs Contribute to the Introduction of Typhoid Conjugate Vaccines?
    Jeon HJ; Im J; Haselbeck A; Holm M; Rakotozandrindrainy R; Bassiahi AS; Panzner U; Mogeni OD; Seo HJ; Lunguya O; Jacobs J; Okeke IN; Terferi M; Owusu-Dabo E; Dougan G; Carey M; Steele AD; Kim JH; Clemens JD; Andrews JR; Park SE; Baker S; Marks F
    Clin Infect Dis; 2019 Oct; 69(Suppl 6):S417-S421. PubMed ID: 31665772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Typhoid Intestinal Perforation in Africa: Results From the Severe Typhoid Fever Surveillance in Africa Program.
    Birkhold M; Datta S; Pak GD; Im J; Ogundoyin OO; Olulana DI; Lawal TA; Afuwape OO; Kehinde A; Phoba MF; Nkoji G; Aseffa A; Teferi M; Yeshitela B; Popoola O; Owusu M; Nana LRW; Cakpo EG; Ouedraogo M; Ouangre E; Ouedraogo I; Heroes AS; Jacobs J; Mogeni OD; Haselbeck A; Sukri L; Neuzil KM; Metila OL; Owusu-Dabo E; Adu-Sarkodie Y; Bassiahi AS; Rakotozandrindrainy R; Okeke IN; Zellweger RM; Marks F
    Open Forum Infect Dis; 2023 May; 10(Suppl 1):S67-S73. PubMed ID: 37274524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000
    Carey ME; Dyson ZA; Ingle DJ; Amir A; Aworh MK; Chattaway MA; Chew KL; Crump JA; Feasey NA; Howden BP; Keddy KH; Maes M; Parry CM; Van Puyvelde S; Webb HE; Afolayan AO; Alexander AP; Anandan S; Andrews JR; Ashton PM; Basnyat B; Bavdekar A; Bogoch II; Clemens JD; da Silva KE; De A; de Ligt J; Diaz Guevara PL; Dolecek C; Dutta S; Ehlers MM; Francois Watkins L; Garrett DO; Godbole G; Gordon MA; Greenhill AR; Griffin C; Gupta M; Hendriksen RS; Heyderman RS; Hooda Y; Hormazabal JC; Ikhimiukor OO; Iqbal J; Jacob JJ; Jenkins C; Jinka DR; John J; Kang G; Kanteh A; Kapil A; Karkey A; Kariuki S; Kingsley RA; Koshy RM; Lauer AC; Levine MM; Lingegowda RK; Luby SP; Mackenzie GA; Mashe T; Msefula C; Mutreja A; Nagaraj G; Nagaraj S; Nair S; Naseri TK; Nimarota-Brown S; Njamkepo E; Okeke IN; Perumal SPB; Pollard AJ; Pragasam AK; Qadri F; Qamar FN; Rahman SIA; Rambocus SD; Rasko DA; Ray P; Robins-Browne R; Rongsen-Chandola T; Rutanga JP; Saha SK; Saha S; Saigal K; Sajib MSI; Seidman JC; Shakya J; Shamanna V; Shastri J; Shrestha R; Sia S; Sikorski MJ; Singh A; Smith AM; Tagg KA; Tamrakar D; Tanmoy AM; Thomas M; Thomas MS; Thomsen R; Thomson NR; Tupua S; Vaidya K; Valcanis M; Veeraraghavan B; Weill FX; Wright J; Dougan G; Argimón S; Keane JA; Aanensen DM; Baker S; Holt KE;
    Elife; 2023 Sep; 12():. PubMed ID: 37697804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multicenter Cost-of-Illness and Long-term Socioeconomic Follow-up Study in the Severe Typhoid Fever in Africa Program: Study Protocol.
    Ramani E; Park S; Toy T; Panzner U; Mogeni OD; Im J; Cruz Espinoza LM; Jeon HJ; Pak GD; Seo H; Chon Y; Rakotozandrindrainy R; Owusu-Dabo E; Osei I; Soura AB; Teferi M; Marks F; Mogasale V
    Clin Infect Dis; 2019 Oct; 69(Suppl 6):S459-S465. PubMed ID: 31665774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the subnational prevalence of antimicrobial resistant Salmonella enterica serovars Typhi and Paratyphi A infections in 75 endemic countries, 1990-2019: a modelling study.
    GRAM Typhoid Collaborators
    Lancet Glob Health; 2024 Mar; 12(3):e406-e418. PubMed ID: 38365414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial.
    Jin C; Gibani MM; Moore M; Juel HB; Jones E; Meiring J; Harris V; Gardner J; Nebykova A; Kerridge SA; Hill J; Thomaides-Brears H; Blohmke CJ; Yu LM; Angus B; Pollard AJ
    Lancet; 2017 Dec; 390(10111):2472-2480. PubMed ID: 28965718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the relationship between ciprofloxacin prescription and non-susceptibility in Salmonella Typhi in Blantyre, Malawi: an observational study.
    Ashton PM; Chunga Chirambo A; Meiring JE; Patel PD; Mbewe M; Silungwe N; Chizani K; Banda H; Heyderman RS; Dyson ZA; MacPherson P; Henrion MYR; ; Holt KE; Gordon MA
    Lancet Microbe; 2024 Mar; 5(3):e226-e234. PubMed ID: 38387472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Typhoid Fever Surveillance in Africa Program (TSAP): Clinical, Diagnostic, and Epidemiological Methodologies.
    von Kalckreuth V; Konings F; Aaby P; Adu-Sarkodie Y; Ali M; Aseffa A; Baker S; Breiman RF; Bjerregaard-Andersen M; Clemens JD; Crump JA; Cruz Espinoza LM; Deerin JF; Gasmelseed N; Sow AG; Im J; Keddy KH; Cosmas L; May J; Meyer CG; Mintz ED; Montgomery JM; Olack B; Pak GD; Panzner U; Park SE; Rakotozandrindrainy R; Schütt-Gerowitt H; Soura AB; Warren MR; Wierzba TF; Marks F
    Clin Infect Dis; 2016 Mar; 62 Suppl 1(Suppl 1):S9-S16. PubMed ID: 26933028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of enteric fever at three urban sites in Africa and Asia: a multicentre population-based study.
    Meiring JE; Shakya M; Khanam F; Voysey M; Phillips MT; Tonks S; Thindwa D; Darton TC; Dongol S; Karkey A; Zaman K; Baker S; Dolecek C; Dunstan SJ; Dougan G; Holt KE; Heyderman RS; Qadri F; Pitzer VE; Basnyat B; Gordon MA; Clemens J; Pollard AJ;
    Lancet Glob Health; 2021 Dec; 9(12):e1688-e1696. PubMed ID: 34798028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population structure of Salmonella enterica Typhi in Harare, Zimbabwe (2012-19) before typhoid conjugate vaccine roll-out: a genomic epidemiology study.
    Thilliez G; Mashe T; Chaibva BV; Robertson V; Bawn M; Tarupiwa A; Takawira FT; Kock MM; Midzi S; Mwamakamba LW; Matheu J; Juru A; Kingsley RA; Ehlers MM
    Lancet Microbe; 2023 Dec; 4(12):e1005-e1014. PubMed ID: 37952554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HPAfrica protocol: Assessment of health behaviour and population-based socioeconomic, hygiene behavioural factors - a standardised repeated cross-sectional study in multiple cohorts in sub-Saharan Africa.
    Pak GD; Haselbeck AH; Seo HW; Osei I; Amuasi J; Breiman RF; Cruz Espinosa LM; Holm M; Im J; Jang GH; Jeon HJ; Luby SP; Lunguya-Metila O; MacWright W; Mogeni OD; Okeke IN; Owusu-Dabo E; Park JK; Park SE; Popoola O; Seo HJ; Soura AB; Teferi M; Toy T; Chon Y; Rafindrakalia M; Rakotozandrindrainy R; Meyer CG; Marks F; Panzner U
    BMJ Open; 2018 Dec; 8(12):e021438. PubMed ID: 30573477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Typhoid and Paratyphoid Collaborators
    Lancet Infect Dis; 2019 Apr; 19(4):369-381. PubMed ID: 30792131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based incidence of typhoid fever in an urban informal settlement and a rural area in Kenya: implications for typhoid vaccine use in Africa.
    Breiman RF; Cosmas L; Njuguna H; Audi A; Olack B; Ochieng JB; Wamola N; Bigogo GM; Awiti G; Tabu CW; Burke H; Williamson J; Oundo JO; Mintz ED; Feikin DR
    PLoS One; 2012; 7(1):e29119. PubMed ID: 22276105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial.
    Qadri F; Khanam F; Liu X; Theiss-Nyland K; Biswas PK; Bhuiyan AI; Ahmmed F; Colin-Jones R; Smith N; Tonks S; Voysey M; Mujadidi YF; Mazur O; Rajib NH; Hossen MI; Ahmed SU; Khan A; Rahman N; Babu G; Greenland M; Kelly S; Ireen M; Islam K; O'Reilly P; Scherrer KS; Pitzer VE; Neuzil KM; Zaman K; Pollard AJ; Clemens JD
    Lancet; 2021 Aug; 398(10301):675-684. PubMed ID: 34384540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Typhoid Fever Surveillance, Incidence Estimates, and Progress Toward Typhoid Conjugate Vaccine Introduction - Worldwide, 2018-2022.
    Hancuh M; Walldorf J; Minta AA; Tevi-Benissan C; Christian KA; Nedelec Y; Heitzinger K; Mikoleit M; Tiffany A; Bentsi-Enchill AD; Breakwell L
    MMWR Morb Mortal Wkly Rep; 2023 Feb; 72(7):171-176. PubMed ID: 36795626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase II, Randomized, Double-blind, Controlled Safety and Immunogenicity Trial of Typhoid Conjugate Vaccine in Children Under 2 Years of Age in Ouagadougou, Burkina Faso: A Methods Paper.
    Laurens MB; Sirima SB; Rotrosen ET; Siribie M; Tiono A; Ouedraogo A; Liang Y; Jamka LP; Kotloff KL; Neuzil KM
    Clin Infect Dis; 2019 Mar; 68(Suppl 2):S59-S66. PubMed ID: 30845330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.